Logo image of INVX

INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

NYSE:INVX - New York Stock Exchange, Inc. - US4576511079 - Common Stock - Currency: USD

16.17  +0.15 (+0.94%)

After market: 16.17 0 (0%)

Fundamental Rating

7

INVX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 63 industry peers in the Energy Equipment & Services industry. INVX gets an excellent profitability rating and is at the same time showing great financial health properties. INVX is growing strongly while it is still valued neutral. This is a good combination! These ratings could make INVX a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year INVX was profitable.
INVX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INVX reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: INVX reported negative operating cash flow in multiple years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of INVX (12.97%) is better than 95.24% of its industry peers.
INVX has a Return On Equity of 15.85%. This is amongst the best in the industry. INVX outperforms 80.95% of its industry peers.
With a decent Return On Invested Capital value of 9.11%, INVX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA 12.97%
ROE 15.85%
ROIC 9.11%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

INVX has a better Profit Margin (17.21%) than 95.24% of its industry peers.
INVX's Profit Margin has improved in the last couple of years.
INVX has a Operating Margin of 13.44%. This is in the better half of the industry: INVX outperforms 66.67% of its industry peers.
INVX's Operating Margin has improved in the last couple of years.
The Gross Margin of INVX (34.30%) is better than 69.84% of its industry peers.
In the last couple of years the Gross Margin of INVX has grown nicely.
Industry RankSector Rank
OM 13.44%
PM (TTM) 17.21%
GM 34.3%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INVX is destroying value.
INVX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, INVX has more shares outstanding
INVX has a worse debt/assets ratio than last year.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 4.92 indicates that INVX is not in any danger for bankruptcy at the moment.
The Altman-Z score of INVX (4.92) is better than 92.06% of its industry peers.
INVX has a debt to FCF ratio of 0.22. This is a very positive value and a sign of high solvency as it would only need 0.22 years to pay back of all of its debts.
INVX's Debt to FCF ratio of 0.22 is amongst the best of the industry. INVX outperforms 92.06% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that INVX is not too dependend on debt financing.
INVX has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. INVX outperforms 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.22
Altman-Z 4.92
ROIC/WACC0.97
WACC9.36%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 4.34 indicates that INVX has no problem at all paying its short term obligations.
INVX has a Current ratio of 4.34. This is amongst the best in the industry. INVX outperforms 90.48% of its industry peers.
INVX has a Quick Ratio of 2.49. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
INVX has a Quick ratio of 2.49. This is amongst the best in the industry. INVX outperforms 87.30% of its industry peers.
Industry RankSector Rank
Current Ratio 4.34
Quick Ratio 2.49
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

9

3. Growth

3.1 Past

INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 169.74%, which is quite impressive.
Measured over the past years, INVX shows a very strong growth in Earnings Per Share. The EPS has been growing by 123.23% on average per year.
Looking at the last year, INVX shows a very strong growth in Revenue. The Revenue has grown by 103.21%.
The Revenue has been growing by 9.76% on average over the past years. This is quite good.
EPS 1Y (TTM)169.74%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%140.32%
Revenue 1Y (TTM)103.21%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%117.98%

3.2 Future

INVX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 134.09% yearly.
The Revenue is expected to grow by 38.17% on average over the next years. This is a very strong growth
EPS Next Y450.7%
EPS Next 2Y134.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year89.54%
Revenue Next 2Y38.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.51, the valuation of INVX can be described as expensive.
63.49% of the companies in the same industry are cheaper than INVX, based on the Price/Earnings ratio.
INVX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 13.67, INVX is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as INVX.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.39, INVX is valued a bit cheaper.
Industry RankSector Rank
PE 30.51
Fwd PE 13.67
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

INVX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. INVX is more expensive than 65.08% of the companies in the same industry.
65.08% of the companies in the same industry are more expensive than INVX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.89
EV/EBITDA 6.63
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INVX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as INVX's earnings are expected to grow with 134.09% in the coming years.
PEG (NY)0.07
PEG (5Y)0.25
EPS Next 2Y134.09%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INVX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVEX INTERNATIONAL INC

NYSE:INVX (6/10/2025, 8:04:01 PM)

After market: 16.17 0 (0%)

16.17

+0.15 (+0.94%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)N/A N/A
Inst Owners47.97%
Inst Owner Change4.59%
Ins Owners1.52%
Ins Owner Change7.03%
Market Cap1.12B
Analysts45.71
Price Target16.32 (0.93%)
Short Float %N/A
Short Ratio6.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP48.35%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.25%
Min EPS beat(2)-22.68%
Max EPS beat(2)49.19%
EPS beat(4)1
Avg EPS beat(4)-48.57%
Min EPS beat(4)-165.36%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-180.4%
EPS beat(12)3
Avg EPS beat(12)-83.27%
EPS beat(16)3
Avg EPS beat(16)-116.41%
Revenue beat(2)2
Avg Revenue beat(2)8.68%
Min Revenue beat(2)7.14%
Max Revenue beat(2)10.21%
Revenue beat(4)3
Avg Revenue beat(4)6.28%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)10.25%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.67%
EPS NQ rev (1m)-17.5%
EPS NQ rev (3m)-1%
EPS NY rev (1m)-17.56%
EPS NY rev (3m)4.38%
Revenue NQ rev (1m)2.68%
Revenue NQ rev (3m)2.68%
Revenue NY rev (1m)-10.37%
Revenue NY rev (3m)74.23%
Valuation
Industry RankSector Rank
PE 30.51
Fwd PE 13.67
P/S 1.24
P/FCF 9.89
P/OCF 8.67
P/B 1.14
P/tB 1.4
EV/EBITDA 6.63
EPS(TTM)0.53
EY3.28%
EPS(NY)1.18
Fwd EY7.32%
FCF(TTM)1.63
FCFY10.11%
OCF(TTM)1.86
OCFY11.53%
SpS13.06
BVpS14.18
TBVpS11.57
PEG (NY)0.07
PEG (5Y)0.25
Profitability
Industry RankSector Rank
ROA 12.97%
ROE 15.85%
ROCE 11.53%
ROIC 9.11%
ROICexc 9.74%
ROICexgc 11.93%
OM 13.44%
PM (TTM) 17.21%
GM 34.3%
FCFM 12.51%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.22
Debt/EBITDA 0.12
Cap/Depr 39.09%
Cap/Sales 1.76%
Interest Coverage 250
Cash Conversion 79.51%
Profit Quality 72.7%
Current Ratio 4.34
Quick Ratio 2.49
Altman-Z 4.92
F-Score5
WACC9.36%
ROIC/WACC0.97
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)169.74%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%140.32%
EPS Next Y450.7%
EPS Next 2Y134.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)103.21%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%117.98%
Revenue Next Year89.54%
Revenue Next 2Y38.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9153.17%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year-16.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y211.64%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y263.32%
OCF growth 3Y34.47%
OCF growth 5Y44.76%